Therapeutic Area
Acute Coronary Syndrome Clinical Trials — Amavita Research
Cardiovascular trial site for acute coronary syndrome, conducted at amavita Heart and Vascular Health® in North Miami Beach, FL.
Acute coronary syndrome — encompassing unstable angina, NSTEMI, and STEMI — drives roughly 800,000 U.S. heart attacks each year. Modern ACS trials test secondary-prevention antithrombotic and lipid-lowering strategies in patients clinically stable after the index event. Here is what Amavita Research is currently running in this space.
Active trials at Amavita Research
- LIBREXIA-ACS
Sponsor: Janssen · Phase 3
Pivotal Phase 3 LIBREXIA-ACS study evaluating a novel antithrombotic strategy in patients following an acute coronary syndrome event.
Principal Investigators in this area
Why Amavita Research for acute coronary syndrome trials
- 24/7 cath-lab access via the affiliated Advanced Cardiovascular of Miami ambulatory surgical center.
- Interventional cardiology PI on staff: Dr. Pedro Martinez-Clark, MD, FACC.
- Door-to-balloon protocols established and audited routinely.
- Post-ACS patients followed inside amavita Heart and Vascular Health® cardiology clinic — meaning trial subjects stay attached to the practice for routine follow-up, lowering drop-out rates.
- Active enrollment on Phase 3 LIBREXIA-ACS (Janssen 70033093ACS3003) post-ACS antithrombotic study.
Think you might be eligible for a acute coronary syndrome trial?
Call (786) 703-5941 or use the patient contact form — initial screening is free and takes about 15 minutes.